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Background

Percentage of Ophthalmology Follow-ups (%)

Type 2 diabetes mellitus is one of the major causes of vision
loss in the United States, and it is estimated to cause diabetic
retinopathy in around 4.2 million adults in the United States
(Zhang et al., 2010). Although current diabetic retinopathy
screenings are very effective, many diabetes mellitus patients
are not up-to-date on routine eye exams (Lu et al., 2016).

Results

Aim Statement
The aim of our project is to improve the diabetic retinopathy
screenings from 5% to 20% until February 2022 within the
endocrinology clinic.
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Medical records of patients with diabetes mellitus were
evaluated from June 2021 to November 2021 (N=1270).
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After 3 months of interventions, patient’s records were reevaluated to obtain percentage of patients who have up-todate eye exams from ophthalmologists after the
interventions.

We will re-educate all staff that are responsible for
encountering diabetic mellitus patients to ask about their last
ophthalmology follow-up eye exam.
o Education will consist of re-enforcing staff every day
the need to ask patients.
o The staff will then ask patients their ophthalmologists
and obtain the last progress note from the
ophthalmology clinics.
o If patients do not have an ophthalmologist or has not
followed up with the ophthalmologist within the last 12
months, follow-up with ophthalmology will be
emphasized during the clinic visit.
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Next Step

At the start of the project, the percentage of patients who
have up-to-date eye exams from ophthalmologists was
obtained.
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Prior to Intervention
DM (# pts) Retinopathy (# pts) Percentage (%)
245
25
10.2%
222
30
13.51%
318
44
13.84%
785
99
12.61%
After Intervention (Educating Staff)
DM (# pts) Retinopathy (# pts) Percentage (%)
172
24
13.95%
191
35
18.32%
122
20
16.39%
485
79
16.29%

In addition to the staff asking patients about ophthalmology
follow-ups, the endocrinologist will ask patients with
diabetes mellitus about ophthalmology follow-ups every visit.
After another 3 months of interventions, the percentage of
patients who have up-to-date eye exams from
ophthalmologists will be obtained and evaluated.
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